EXPRESSION OF CONCERN: Potent Anti-amyloidogenic and Fibril-destabilizing Effects of Polyphenols In Vitro: Implications for the Prevention and Therapeutics of Alzheimer’s Disease

IF 4.2 3区医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

Journal of Neurochemistry Pub Date : 2024-12-09 DOI:10.1111/jnc.16285

{"title":"EXPRESSION OF CONCERN: Potent Anti-amyloidogenic and Fibril-destabilizing Effects of Polyphenols In Vitro: Implications for the Prevention and Therapeutics of Alzheimer’s Disease","authors":"","doi":"10.1111/jnc.16285","DOIUrl":null,"url":null,"abstract":"EXPRESSION OF CONCERN: K. Ono, Y. Yoshiike, A. Takashima, K. Hasegawa, H. Naiki and M. Yamada, “Potent Anti-amyloidogenic and Fibril-destabilizing Effects of Polyphenols In Vitro: Implications for the Prevention and Therapeutics of Alzheimer's Disease,” Journal of Neurochemistry 87, no. 1 (2003): 172–181, https://doi.org/10.1046/j.1471-4159.2003.01976.x.This Expression of Concern for the above article, published online on 12 September 2003 in Wiley Online Library (wileyonlinelibrary.com), has been published by agreement between the journal Editor-in-Chief, Andrew Lawrence; the International Society for Neurochemistry; and John Wiley and Sons Ltd. The Expression of Concern has been agreed due to concerns over the duplication of Figure 5, panel a, which was later published elsewhere in another article by some of the same authors. The same images were used to represent different experimental conditions. The journal would like to issue this Expression of Concern to alert readers while an investigation takes place at the author's institution.","PeriodicalId":16527,"journal":{"name":"Journal of Neurochemistry","volume":"169 1","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jnc.16285","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurochemistry","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jnc.16285","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

EXPRESSION OF CONCERN: K. Ono, Y. Yoshiike, A. Takashima, K. Hasegawa, H. Naiki and M. Yamada, “Potent Anti-amyloidogenic and Fibril-destabilizing Effects of Polyphenols In Vitro: Implications for the Prevention and Therapeutics of Alzheimer's Disease,” Journal of Neurochemistry 87, no. 1 (2003): 172–181, https://doi.org/10.1046/j.1471-4159.2003.01976.x.

This Expression of Concern for the above article, published online on 12 September 2003 in Wiley Online Library (wileyonlinelibrary.com), has been published by agreement between the journal Editor-in-Chief, Andrew Lawrence; the International Society for Neurochemistry; and John Wiley and Sons Ltd. The Expression of Concern has been agreed due to concerns over the duplication of Figure 5, panel a, which was later published elsewhere in another article by some of the same authors. The same images were used to represent different experimental conditions. The journal would like to issue this Expression of Concern to alert readers while an investigation takes place at the author's institution.

查看原文本刊更多论文

关注的表达：体外多酚有效的抗淀粉样变性和纤维不稳定作用：对阿尔茨海默病的预防和治疗的意义。

关注的表达：K. Ono， Y. Yoshiike， A. Takashima， K. Hasegawa， H. Naiki和M. Yamada，“多酚在体外抗淀粉样变性和纤维蛋白不稳定的作用：对阿尔茨海默病的预防和治疗的意义”，神经化学杂志87，no。1 (2003): 172-181, https://doi.org/10.1046/j.1471-4159.2003.01976.x.This对上述文章的关注表达，于2003年9月12日在线发表在Wiley在线图书馆（wileyonlinelibrary.com）上，经期刊主编Andrew Lawrence；国际神经化学学会；及约翰威利父子有限公司。由于对图5面板a的重复的关注，关注表达已经达成一致，图5面板a后来被一些相同的作者发表在另一篇文章的其他地方。用相同的图像代表不同的实验条件。在作者所在的机构正在进行调查时，本刊希望发出这份关注声明，以提醒读者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Neurochemistry 医学-神经科学

CiteScore

9.30

自引率

2.10%

发文量

181

审稿时长

2.2 months

期刊介绍： Journal of Neurochemistry focuses on molecular, cellular and biochemical aspects of the nervous system, the pathogenesis of neurological disorders and the development of disease specific biomarkers. It is devoted to the prompt publication of original findings of the highest scientific priority and value that provide novel mechanistic insights, represent a clear advance over previous studies and have the potential to generate exciting future research.